View in EDS

CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: a case-based systematic review.

Saved in:
Bibliographic Details
Title: CDK4/6 inhibitor-statin interaction and rhabdomyolysis in breast cancer treatment: a case-based systematic review.
Authors: João RB; Neurology and Neurophysiology Department, Goiânia Neurological Institute, Goiânia, Goiás, Brazil., Soares LR; CORA - Advanced Center for Diagnosis of Breast Diseases, School of Medicine and Hospital das Clínicas, Federal University of Goiás, Goiás, Brazil.; IMO Mastology and Oncology Institute, Goiânia, Goiás, Brazil.; Gynecology and Breast Department, Araújo Jorge Cancer Hospital, Goiás Anticancer Association, Goiânia, Goiás, Brazil., Ragazzo PC; Neurology and Neurophysiology Department, Goiânia Neurological Institute, Goiânia, Goiás, Brazil., Freitas-Junior R; CORA - Advanced Center for Diagnosis of Breast Diseases, School of Medicine and Hospital das Clínicas, Federal University of Goiás, Goiás, Brazil. ruffojr@terra.com.br.; IMO Mastology and Oncology Institute, Goiânia, Goiás, Brazil. ruffojr@terra.com.br.; Gynecology and Breast Department, Araújo Jorge Cancer Hospital, Goiás Anticancer Association, Goiânia, Goiás, Brazil. ruffojr@terra.com.br.
Source: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2026 Jul 01; Vol. 96 (1). Date of Electronic Publication: 2026 Jul 01.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-0843
DOI:10.1007/s00280-026-04913-w